1. 109 CLINICAL AND MOLECULAR PREDICTORS OF RESPONSE TO ERYTHROPOIESIS STIMULATING AGENTS (ESA) IN LOWER RISK MDS PATIENTS. (April 2015) Authors: Kosmider, O.; Passet, M.; Santini, V.; Platzbecker, U.; Andrieu, V.; Zini, G.; Beyne-Rauzy, O.; Guerci, A.; Slama, B.; Fenaux, P.; Dreyfus, F.; Fontenay, M.; Park, S. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 14 A PHASE 2, DOSE-FINDING STUDY OF SOTATERCEPT (ACE-011) IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (MDS) OR NON-PROLIFERATIVE CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) AND ANEMIA REQUIRING TRANSFUSION. (April 2015) Authors: Komrokji, R.; Garcia-Manero, G.; Ades, L.; Laadem, A.; Vo, B.; Prebet, T.; Stamatoullas, A.; Boyd, T.; Delaunay, J.; Steensma, D.P.; Sekeres, M.A.; Beyne-Rauzy, O.; Zou, J.; Attie, K.M.; Sherman, M.L.; Fenaux, P.; List, A.F. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 148 CLONAL EVOLUTION OF HEMATOPOIETIC STEM CELL UNDER TREATMENT BY LENALIDOMIDE IN NON DEL(5Q) MDS. Issue 1 (April 2015) Authors: Chesnais, V.; Renneville, A.; Toma, A.; Passet, M.; Gauthier, A.; Delaunay, J.; Rose, C.; Stamatoullas, A.; Beyne-Rauzy, O.; Fenaux, P.; Dreyfus, F.; Preudhomme, C.; Fontenay, M.; Kosmider, O. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S74 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 213 AZACITIDINE (AZA) IN HIGHER RISK MDS PATIENTS WITH CHROMOSOME 7 ABNORMALITIES (ABN 7): RESULTS OF A RETROSPECTIVE STUDY FROM THE GFM AND GESMD REGISTRIES. Issue 1 (April 2015) Authors: Campelo, M. Díez; Lorenzo, J.I.; Itzykson, R.; Rojas, S.M.; Berthon, C.; Luño, E.; Beyne-Rauzy, O.; Pérez-Oteyza, J.; Vey, N.; Bargay, J.; Park, S.; Cedena, T.; Bordessoule, D.; Muñoz, J.A.; Gyan, E.; Such, E.; Visanica, S.; Benlloch, L.; de Botton, S.; Hernández-Rivas, J.M. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 81 LONG-TERM OUTCOME OF LOWER RISK MDS PATIENTS RECEIVING ESA, AND IMPACT OF POST-ESA TREATMENTS ON SURVIVAL: A RETROSPECTIVE STUDY FROM THE GFM, DÜSSELDORF, AND GESMD REGISTRIES. (April 2015) Authors: Park, S.; Hamel, J.F.; Kelaidi, C.; Campelo, M. Diez; Schemenau, J.; Sapena, R.; Goetze, K.; Mueller-Thomas, K.; Beyne-Rauzy, O.; Stamatoullas, A.; Guerci-Bresler, A.; Cony-Makhoul, P.; Courby, S.; Cheze, S.; Rose, C.; Vey, N.; Germing, U.; Sanz, G.; Fenaux, P.; Dreyfus, F. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 91 IRON CHELATION AND VITAMIN-D3 IN COMBINATION WITH AZACITIDINE IMPROVES TREATMENT RESPONSE IN 19 HIGH RISK MYELODYSPLASTIC SYNDROMES AFTER AZACITIDINE FAILURE. (April 2015) Authors: Brechemier, D.; Comont, T.; Bertoli, S.; Dutertre, M.; Recher, C.; Adoue, D.; Beyne-Rauzy, O. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 92 IMPACT OF COMORBIDITIES AND GERIATRIC ASSESSMENT IN HIGH RISK MYELODYSPLASTIC SYNDROMES OVER 75 YEARS TREATED WITH AZACITIDINE. Issue 1 (April 2015) Authors: Brechemier, D.; Comont, T.; Bertoli, S.; Lozano, S.; Gerard, S.; Adoue, D.; Lauwers-Cances, V.; Beyne-Rauzy, O. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 94 IMPACT OF COMORBIDITIES ON OVERALL SURVIVAL IN THE ELDERLY WITH MYELODYSPLASTIC SYNDROME OR ACUTE MYELOID LEUKEMIA TREATED BY AZACITIDINE. Issue 1 (April 2015) Authors: Brechemier, D.; Bertoli, S.; Comont, T.; Balardy, L.; Recher, C.; Lauwers-Cances, V.; Beyne-Rauzy, O. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. A Retrospective Validation of International Consortium for MDS/MPN Response Criteria in CMML Treated with Hypomethylating Agents. (April 2017) Authors: Duchmann, M.; Braun, T.; Micol, J.B.; Platzbecker, U.; Park, S.; Pilorge, S.; Beyne-Rauzy, O.; Vey, N.; Sébert, M.; Gruson, B.; Dumas, P.Y.; Guieze, R.; Chretien, M.L.; Laribi, K.; Chait, Y.; Legros, L.; Hirsch, P.; Solary, E.; Fenaux, P.; Itzykson, R. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromes. Issue 8 (August 2015) Authors: Caocci, G.; Voso, M.T.; Angelucci, E.; Stauder, R.; Cottone, F.; Abel, G.; Nguyen, K.; Platzbecker, U.; Beyne-Rauzy, O.; Gaidano, G.; Invernizzi, R.; Molica, S.; Criscuolo, M.; Breccia, M.; Lübbert, M.; Sanpaolo, G.; Buccisano, F.; Ricco, A.; Palumbo, G.A.; Niscola, P. Journal: Leukemia research Issue: Volume 39:Issue 8(2015:Aug.) Page Start: 859 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗